Cryoballoon pulmonary vein isolation versus radiofrequency ablation of the pulmonary veins and left atrial posterior wall: Patient-reported outcomes.
atrial fibrillation
cryoballoon ablation
patient reported outcomes
quality of life
radiofrequency ablation
Journal
Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944
Informations de publication
Date de publication:
25 Mar 2024
25 Mar 2024
Historique:
revised:
05
01
2024
received:
08
08
2023
accepted:
23
01
2024
medline:
25
3
2024
pubmed:
25
3
2024
entrez:
25
3
2024
Statut:
aheadofprint
Résumé
Data are lacking on patient-reported outcomes (PRO) following cryoballoon ablation (CBA) versus radiofrequency ablation (RFA). We sought to evaluate QoL and clinical outcomes of cryoballoon pulmonary vein isolation only (CRYO-PVI-ONLY) versus RFA with PVI and posterior wall isolation (RF-PVI+PWI) in a large prospective PRO registry. Patients who underwent AF ablation (2013-2016) at our institution were enrolled in an automated, prospectively maintained PRO registry. CRYO-PVI-ONLY patients were matched (1:1) with RF-PVI+PWI patients based on age, gender, and type of AF (paroxysmal vs. persistent). QoL and clinical outcomes were assessed using PRO surveys at baseline and at 1-year. The atrial fibrillation symptom severity scale (AFSSS) was the measure for QoL. Additionally, we assessed patient-reported clinical improvement, arrhythmia recurrence, and AF burden (as indicated by AF frequency and duration scores). A total of 296 patients were included (148 in each group, 72% paroxysmal). By PRO, a significant improvement in QoL was observed in the overall study population and was comparable between CRYO-PVI-ONLY and RF-PVI+PWI (baseline median AFSSS of 11.5 and 11; reduced to 2 and 4 at 1 year, respectively; p = 0.44). Similarly, the proportion of patients who reported improvement in their overall QoL and AF related symptoms was high and similar between the study groups [92% (CRYO-PVI-ONLY) vs. 92.8% (RF-PVI+PWI); p = 0.88]. Arrhythmia recurrence was significantly more common in the CRYO-PVI-ONLY group (39.7%) compared to RF-PVI+PWI (27.7 %); p = 0.03. Comparable results were observed in paroxysmal and persistent AF. CRYO-PVI-ONLY and RF-PVI+PWI resulted in comparable improvements in patient reported outcomes including QoL and AF burden; with RF-PVI+PWI being more effective at reducing recurrences.
Sections du résumé
BACKGROUND
BACKGROUND
Data are lacking on patient-reported outcomes (PRO) following cryoballoon ablation (CBA) versus radiofrequency ablation (RFA). We sought to evaluate QoL and clinical outcomes of cryoballoon pulmonary vein isolation only (CRYO-PVI-ONLY) versus RFA with PVI and posterior wall isolation (RF-PVI+PWI) in a large prospective PRO registry.
METHODS
METHODS
Patients who underwent AF ablation (2013-2016) at our institution were enrolled in an automated, prospectively maintained PRO registry. CRYO-PVI-ONLY patients were matched (1:1) with RF-PVI+PWI patients based on age, gender, and type of AF (paroxysmal vs. persistent). QoL and clinical outcomes were assessed using PRO surveys at baseline and at 1-year. The atrial fibrillation symptom severity scale (AFSSS) was the measure for QoL. Additionally, we assessed patient-reported clinical improvement, arrhythmia recurrence, and AF burden (as indicated by AF frequency and duration scores).
RESULTS
RESULTS
A total of 296 patients were included (148 in each group, 72% paroxysmal). By PRO, a significant improvement in QoL was observed in the overall study population and was comparable between CRYO-PVI-ONLY and RF-PVI+PWI (baseline median AFSSS of 11.5 and 11; reduced to 2 and 4 at 1 year, respectively; p = 0.44). Similarly, the proportion of patients who reported improvement in their overall QoL and AF related symptoms was high and similar between the study groups [92% (CRYO-PVI-ONLY) vs. 92.8% (RF-PVI+PWI); p = 0.88]. Arrhythmia recurrence was significantly more common in the CRYO-PVI-ONLY group (39.7%) compared to RF-PVI+PWI (27.7 %); p = 0.03. Comparable results were observed in paroxysmal and persistent AF.
CONCLUSION
CONCLUSIONS
CRYO-PVI-ONLY and RF-PVI+PWI resulted in comparable improvements in patient reported outcomes including QoL and AF burden; with RF-PVI+PWI being more effective at reducing recurrences.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Zhang J, Johnsen SP, Guo Y, Lip GYH. Epidemiology of atrial fibrillation: geographic/ecological risk factors, age, sex, genetics. Card Electrophysiol Clin. 2021;13:1‐23.
Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982‐3021.
Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow‐up, definitions, endpoints, and research trial design: a re. EP Eur [Internet]. 2012;14:528‐606. . Available from doi:10.1093/europace/eus027
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R. J Am Coll Cardiol. 2019;74:104‐132.
Kuck KH, Brugada J, Fürnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:393‐394.
Malmborg H, Lönnerholm S, Blomström P, Blomström‐Lundqvist C. Ablation of atrial fibrillation with cryoballoon or duty‐cycled radiofrequency pulmonary vein ablation catheter: a randomized controlled study comparing the clinical outcome and safety; the AF‐COR study. Europace. 2013;15:1567‐1573.
Andrade JG, Champagne J, Dubuc M, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation. 2019;140:1779‐1788.
Chen C, Gao X, Duan X, Chen B, Liu X, Xu Y. Comparison of catheter ablation for paroxysmal atrial fibrillation between cryoballoon and radiofrequency: a meta‐analysis. J Interv Card Electrophysiol. 2017;48:351‐366.
Hussein AA, Lindsay B, Madden R, et al. New model of automated patient‐reported outcomes applied in atrial fibrillation. Circ Arrhythmia Electrophysiol. 2019;12:e006986.
Farwati M, Wazni OM, Tarakji KG, et al. Super and nonresponders to catheter ablation for atrial fibrillation: a quality‐of‐life assessment using patient reported outcomes. Circ Arrhythm Electrophysiol. 2021:14.
Basch E. Patient‐reported outcomes—harnessing patients’ voices to improve clinical care. N Engl J Med. 2017;376:105‐108.
Hussein AA, Lindsay B, Madden R, et al. New model of automated patient‐reported outcomes applied in atrial fibrillation. Circ Arrhythm Electrophysiol. 2019:12.
Dorian P, Jung W, Newman D, et al. The impairment of health‐related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36:1303‐1309.
Dorian P, Guerra PG, Kerr CR, et al. Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale. Circ Arrhythmia Electrophysiol. 2009;2:218‐224.
Kanj MH, Wazni OM, Natale A. How to do circular mapping catheter‐guided pulmonary vein antrum isolation: the Cleveland Clinic approach. Hear Rhythm. 2006;3:866‐869.
Hussein AA, Martin DO, Saliba W, et al. Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Hear Rhythm. 2009;6:1425‐1429.
Shah S, Barakat AF, Saliba WI, et al. Recurrent atrial fibrillation after initial long‐term ablation success: electrophysiological findings and outcomes of repeat ablation procedures. Circ Arrhythm Electrophysiol. 2018:11.
Wazni OM, Dandamudi G, Sood N, et al. CBACBA as initial therapy for atrial fibrillation. N Engl J Med. 2021;384:316‐324.
Thrall G, Lane D, Carroll D, Lip GYH. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119:448. e1.
Humphries B, Cox JL, Parkash R, et al. Patient‐reported outcomes and patient‐reported experience of patients with atrial fibrillation in the impact‐AF clinical trial. J Am Heart Assoc. 2021;10:e019783.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Kardiol Pol (Polish Hear Journal). 2016;74:1359‐1469.
Boveda S, Metzner A, Nguyen DQ, et al. Single‐procedure outcomes and quality‐of‐life improvement 12 months post‐CBACBA in persistent atrial fibrillation: results from the multicenter CRYO4PERSISTENT AF trial. JACC Clin Electrophysiol. 2018;4:1440‐1447.
Kuck KH, Fürnkranz A, Chun KRJ, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality‐of‐life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37:2858‐2865.
Blomström‐Lundqvist C, Gizurarson S, Schwieler J, et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial. Jama. 2019;321:1059‐1068.
Andrade JG, Macle L, Verma A, et al. Quality of life and health care utilization in the CIRCA‐DOSE study. Clin Electrophysiol. 2020;6:935‐944.
Samuel M, Khairy P, Champagne J, et al. Association of atrial fibrillation burden with health‐related quality of life after atrial fibrillation ablation: substudy of the cryoballoon vs contact‐force atrial fibrillation ablation (CIRCA‐DOSE) randomized clinical trial. JAMA Cardiol. 2021;6:1324‐1328.
Gupta D, Vijgen J, De Potter T, et al. Quality of life and healthcare utilisation improvements after atrial fibrillation ablation. Heart. 2021;107:1296‐1302.
Farwati M, Wazni OM, Tarakji KG, et al. Super and non‐responders to catheter ablation for atrial fibrillation: a quality‐of‐life assessment using patient reported outcomes. Circ Arrhythmia Electrophysiol. 2021.
Elsayed M, Abdelfattah OM, Sayed A, et al. Bayesian network meta‐analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation. J Cardiovasc Electrophysiol. 2022;33:197‐208.